San Diego Biotechnology Connection

Helping biotech investors improve their portfolios\' performance

Biotechs A

More insurers, ObamaCare to cover obesity drugs made by Arena, Vivus

Qsymia capsules, Vivus, Inc., San Diego Biotechnology Connection

Qsymia capsules. Image: Vivus, Inc. By Rex Graham This season of pumpkin pie, mashed potatoes and rising obesity rates is a perfect time to talk turkey about the overly bearish sales estimates of Belviq and Qsymia, the obesity drugs approved by the FDA this summer. The oft-cited $1 billion-a-year combined estimated sales for Qsymia, which is made by Vivus, Inc. (VVUS), and Belviq, made by Arena Pharmaceuticals...

Biotechs B-D

Cardium boosts energy supplement sales with national marketing muscle

Neo-Chill, Cardium Therapeutics, San Diego Biotechnology Connection

Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network is expected to expand sales of Cardium’s nutraceutical products, such as Neo-Chill, which promotes relaxation without drowsiness and contains Suntheanine, a patented, proprietary L-theanine (an amino acid) also found in green tea. Photo: Cardium Therapeutics By Rex Graham Cardium Therapeutics (CXM), a biotech...

Biotechs E-H

Glaxo genital herpes vaccine flops but Agenus a buy in vaccine space

Genital herpes vaccine, NIH, San Diego Biotechnology Connection

Agenus, Inc. (Nasdaq: AGEN), and Genocea Biosciences are pursuing protein subunit vaccines against genital herpes, or herpes simplex virus type 2 (HSV-2). Image: NIH By Rex Graham A Glaxo Smith Kline (Nasdaq: GSK) genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc. (Nasdaq: AGEN), Vical, Inc., (Nasdaq:...

Biotechs I-M

Scientists like MediciNova treatment for methamphetamine addiction

Quitting methamphetamine

Withdrawal from a methamphetamine addiction makes users feeling “foggy,” slow and unable to continuously concentrate on many tasks. By Rex Graham Scientists who have evaluated a variety of drug candidates to treat methamphetamine addiction (all of which failed in efficacy tests) are “gleeful” about significant positive clinical results of a novel type of drug being development by San Diego...

Biotechs N-Q

Spinal fusion innovator Nuvasive poised for medical device breakout year

Nuvasive, San Diego Biotechnology Connection

Spinal fusion innovator Nuvasive, Inc., is one of the biggest beneficiaries of federal enforcement actions aimed at “shell” medical device companies, and a new meta-analysis that casts doubt on a widely used Medtronic spinal fusion treatment. By Rex Graham It’s rare for a $1.3 billion market to suddenly open up in the fiercely competitive spinal implant device space. However, federal regulators...

Biotechs T-Z

Trius: dump or double down on maker of MRSA antibiotic?

MRSA, University of Wisconsin, San Diego Biotechnology Connection

Trius Therapeutics has developed an antibiotic to treat infections caused by the deadly superbug called methicillin-resistant Staphylococcus aureus (MRSA), photographed here growing on a culture plate being held by Warren Rose, an associate professor of pharmacy at the University of Wisconsin.(Photo: John Maniaci, University of Wisconsin Hospital & Clinics) By Rex Graham The share price of Trius...